Here’s Why Farfetch Shares Are Rallying After Hours
Farfetch (NYSE: FTCH) shares are trading higher after the company reported better-than-expected Q1 results, with EPS and sales beating consensus estimates.
‘Japan to subsidize half of costs for lithium and key mineral projects’ -Nikkei
https://asia.nikkei.com/Economy/Japan-to-subsidize-half-of-costs-for-lithium-and-key-mineral-projects#:~:text=Japan%20to%20subsidize%20half%20of%20costs%20for%20lithium%20and%20key%20mineral%20projects,-Push%20to%20reduc https://asia.nikkei.com/Economy/Japan-to-subsidize-half-of-costs-for-lithium-and-key-mineral-projects#:~:text=Japan%20to%20subsidize%20half%20of%20costs%20for%20lithium%20and%20key%20mineral%20projects,-Push%20to%20reduce&text=TOKYO%20%2D%2D%20The%20Ministry%20of,Japanese%20companies%2C%20Nikkei%20has%20learned.
ImmunoPrecise’s Subsidiary Talem Enters Exclusive Research Collaboration And License Option Agreement With Astellas
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("ImmunoPrecise" or "IPA" or the "Company") an AI-driven biotherapeutic research and technology company today announced a research collaboration
Xeris Biopharma Announces Research Evaluation Collaboration And Option Agreement With Regeneron For XeriJect
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas,
Medical Properties Trust Announces Agreement To Sell Healthscope Portfolio; Cash Proceeds Of Approximately AUD$1.2B To Fully Prepay Term Loan Maturing In 2024
Cash Proceeds of Approximately AUD$1.2 Billion to Fully Prepay Term Loan Maturing in 2024
Investor Appetite for Hospitals Remains Strong
Forbes On Friday Reported Luminar Was Accused Of Using Image Of Rival’s Chip In Investor Conference
https://www.forbes.com/sites/alanohnsman/2023/03/17/lidar-maker-luminar-accused-of-using-image-of-rivals-chip-in-investor-conference/?sh=2fb6c684abf3
‘UBS in talks to acquire Credit Suisse’ -FT, Citing Multiple People Briefed On The Talks
https://www.ft.com/content/17892f24-4ca0-417f-9093-289b019a0852